This inventor holds 1 USPTO granted patent. Top assignees: Duke University, Pharmaceuticals Corporation. Active years: 1995.
Company Filing History:
1 out of 2,075 
1 out of 2 Years Active: 1995
Title: The Innovations of Lawrence M Ballas
Introduction
Lawrence M Ballas is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in combating multidrug resistance in cancer treatment. His innovative work has the potential to enhance the effectiveness of antineoplastic agents.
Latest Patents
One of his key patents is titled "Aminoanthraquinone derivatives to combat multidrug resistance." This patent focuses on potentiating agents that inhibit the development of multidrug resistance, reduce drug resistance in drug-resistant tumors, or sensitize tumors to antineoplastic drugs. The potentiating agents are aminoanthraquinones, preferably 1,4-bis(N-substituted) amino anthraquinones, and pharmaceutically acceptable salts thereof. This invention represents a significant advancement in cancer therapy.
Career Highlights
Throughout his career, Lawrence M Ballas has worked with esteemed institutions such as Duke University and Pharmaceuticals Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.
Collaborations
Lawrence has collaborated with notable individuals in his field, including Clifford W Sachs and Robert L Fine. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Lawrence M Ballas is a distinguished inventor whose work in developing aminoanthraquinone derivatives has the potential to revolutionize cancer treatment. His contributions to the field highlight the importance of innovation in overcoming medical challenges.